Seated saline suppression testing for the diagnosis of primary aldosteronism: A preliminary study

Journal of Clinical Endocrinology and Metabolism

Volumn 99, Issue 8, 2014, Pages 2745-2753

  Ahmed, Ashraf H ^a   Cowley, Diane ^a   Wolley, Martin ^a   Gordon, Richard D ^a   Xu, Shengxin ^a   Taylor, Paul J ^a   Stowasser, Michael ^a  

^a UNIVERSITY OF QUEENSLAND   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ADRENAL CORTEX FUNCTION TESTS; ADULT; AGED; ALDOSTERONE; FEMALE; FLUDROCORTISONE; HUMANS; HYPERALDOSTERONISM; MALE; MIDDLE AGED; PILOT PROJECTS; POSTURE; RENIN; SODIUM CHLORIDE;

EID: 84905836989     PISSN: 0021972X     EISSN: 19457197     Source Type: Journal    
DOI: 10.1210/jc.2014-1153     Document Type: Article

References (22)

1. Gordon RD, Klemm SA, Tunny TJ, Stowasser M. Primary aldosteronism: hypertension with a genetic basis. Lancet. 1992;340:159-161.
2. Gordon RD, Stowasser M. Primary aldosteronism: the case for screening. Nat Clin Pract Nephrol. 2007;3:582-583.
3. Stowasser M, Gordon RD. Primary aldosteronism. Best Pract Res Clin Endocrinol Metab. 2003;17:591-605.
4. Holland OB, Brown H, Kuhnert L, Fairchild C, Risk M, Gomez- Sanchez CE. Further evaluation of saline infusion for the diagnosis of primary aldosteronism. Hypertension. 1984;6:717-723.
5. Kem DC, Weinberger MH, Mayes DM, Nugent CA. Saline suppression of plasma aldosterone in hypertension. Arch Intern Med. 1971; 128:380-386.
6. Litchfield WR, Dluhy RG. Primary aldosteronism. Endocrinol Metab Clin North Am. 1995;24:593-612.
7. Giacchetti G, Ronconi V, Lucarelli G, Boscaro M, Mantero F. Analysis of screening and confirmatory tests in the diagnosis of primary aldosteronism: need for a standardized protocol. J Hypertens. 2006; 24:737-745.
8. Mulatero P, Milan A, Fallo F, et al. Comparison of confirmatory tests for the diagnosis of primary aldosteronism. J Clin Endocrinol Metab. 2006;91:2618-2623.
9. Rossi GP, Belfiore A, Bernini G, et al. Prospective evaluation of the saline infusion test for excluding primary aldosteronism due to aldosterone- producing adenoma. J Hypertens. 2007;25:1433-1442.
10. Gordon RD. The challenge of more robust and reproducible methodology in screening for primary aldosteronism. J Hypertens. 2004; 22:251-255.
11. Schirpenbach C, Seiler L, Maser-Gluth C, Beuschlein F, Reincke M, Bidlingmaier M. Automated chemiluminescence-immunoassay for aldosterone during dynamic testing: comparison to radioimmunoassays with and without extraction steps. Clin Chem. 2006;52: 1749-1755.
12. Turpeinen U, Hämäläinen E, Stenman UH. Determination of aldosterone in serum by liquid chromatography-tandem mass spectrometry. J Chromatogr B Analyt Technol Biomed Life Sci. 2008;862: 113-118.
13. Taylor PJ, Cooper DP, Gordon RD, Stowasser M. Measurement of aldosterone in human plasma by semiautomated HPLC-tandem mass spectrometry. Clin Chem. 2009;55:1155-1162.
14. Stowasser M, Taylor PJ, Pimenta E, Ahmed AH, Gordon RD. Laboratory investigation of primary aldosteronism. Clin Biochem Rev. 2010;31:39-56.
15. Fallo F, Barzon L, Biasi F, Altavilla G, Boscaro M, Sonino N. Zona fasciculata-like histotype and aldosterone response to upright posture are not related in aldosterone-producing adenomas. Exp Clin Endocrinol Diabetes. 1998;106:74-78.
16. Funder JW, Carey RM, Fardella C, et al. Case detection, diagnosis, and treatment of patients with primary aldosteronism: an endocrine society clinical practice guideline. J Clin Endocrinol Metab. 2008; 93:3266-3281.
17. Stowasser M, Gordon RD, Rutherford JC, Nikwan NZ, Daunt N, Slater GJ. Diagnosis and management of primary aldosteronism. J Renin Angiotensin Aldosterone Syst. 2001;2:156-169.
18. Loh KC, Koay ES, Khaw MC, Emmanuel SC, Young WF, Jr. Prevalence of primary aldosteronism among Asian hypertensive patients in Singapore. J Clin Endocrinol Metab 2000;85:2854-2859.
19. Biglieri EG, Irony I, Kater CE. Identification and implications ofnew types of mineralocorticoid hypertension. J Steroid Biochem. 1989; 32:199-204.
20. Gordon RD, Stowasser M, Rutherford JC. Primary aldosteronism: are we diagnosing and operating on too few patients? World J Surg. 2001;25:941-947.
21. Stowasser M, Gordon RD, Gunasekera TG, et al. High rate of detection of primary aldosteronism, including surgically treatable forms, after 'non-selective' screening of hypertensive patients. J Hypertens. 2003;21:2149-2157.
22. Willenberg HS, Vonend O, Schott M, et al. Comparison of the saline infusion test and the fludrocortisone suppression test for the diagnosis of primary aldosteronism. Horm Metab Res. 2012;44:527-532.